Stacy A. Decker, Ph.D.
Affiliations: | 2012 | Neuroscience | University of Minnesota, Twin Cities, Minneapolis, MN |
Area:
Neuroscience Biology, OncologyGoogle:
"Stacy Decker"Mean distance: 53433
Parents
Sign in to add mentorJohn Ohlfest | grad student | 2012 | UMN | |
(A spontaneous murine model for the study of CD44 in glioma progression.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Soroceanu L, Matlaf L, Khan S, et al. (2015) Cytomegalovirus Immediate-Early Proteins Promote Stemness Properties in Glioblastoma. Cancer Research. 75: 3065-76 |
Agarwal S, Mittapalli RK, Zellmer DM, et al. (2012) Active efflux of Dasatinib from the brain limits efficacy against murine glioblastoma: broad implications for the clinical use of molecularly targeted agents. Molecular Cancer Therapeutics. 11: 2183-92 |
Murphy KA, Lechner MG, Popescu FE, et al. (2012) An in vivo immunotherapy screen of costimulatory molecules identifies Fc-OX40L as a potent reagent for the treatment of established murine gliomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 4657-68 |
Fujita M, Kohanbash G, Fellows-Mayle W, et al. (2011) COX-2 blockade suppresses gliomagenesis by inhibiting myeloid-derived suppressor cells. Cancer Research. 71: 2664-74 |
Fujita M, Kohanash G, Fellows-Mayle W, et al. (2011) Abstract 1788: COX-2 blockade suppresses gliomagenesis by inhibiting CCL2-mediated accumulation of myeloid-derived suppressor cells Cancer Research. 71: 1788-1788 |
Fujita M, Scheurer ME, Decker SA, et al. (2010) Role of type 1 IFNs in antiglioma immunosurveillance--using mouse studies to guide examination of novel prognostic markers in humans. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 3409-19 |
Fujita M, Decker SA, Popescu F, et al. (2010) Abstract 1359: COX2 blockade suppresses glioma-genesis by promoting anti-glioma immunosurveillance Cancer Research. 70: 1359-1359 |
Wiesner SM, Decker SA, Larson JD, et al. (2009) De novo induction of genetically engineered brain tumors in mice using plasmid DNA. Cancer Research. 69: 431-9 |